A collection of studies showed that plasma CCL11 increased in patients with Alzheimer's disease and Huntington's disease, while it decreased in amyotrophic lateral sclerosis and secondary progressive multiple sclerosis [113]–[115]. Here, CCL11 is linked to early-onset autosomal dominant Alzheimer disease.